Product Program year 2025 Source: CMS Open Payments

Edex

Drug Urology

NDC 52244-010-02

Open in the dashboard

General payments

$436,338

24,824 payments

Research payments

$0

0 payments

Through program year 2025, $436,338 in general payments and $0 in research payments were reported against Edex (Urology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $8,671 349
2024 General $14,647 721
2023 General $35,455 1,838
2022 General $111,446 6,266
2021 General $121,403 7,326
2020 General $76,344 4,699
2019 General $68,373 3,625

Breakdown

Who paid General payments · program years 2019–2025
  1. Endo Pharmaceuticals Inc. $418,954 24,043 payments
  2. Endo USA, Inc. $17,384 781 payments
Top recipients General payments · program year 2025
  1. Jesse Mills Urology · Santa Monica, CA $167 2% · 1 payment
  2. James Smith Urology · San Francisco, CA $167 2% · 1 payment
  3. Martin Gelbard Urology · Santa Monica, CA $167 2% · 1 payment
  4. Sriram Eleswarapu Urology · Burbank, CA $167 2% · 1 payment
  5. John Lindsey Urology · San Francisco, CA $167 2% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $6,050 71% · 141 practitioners
  2. Physician Assistant $968 11% · 27 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $426 5% · 14 practitioners
  4. Nurse Practitioner $396 5% · 11 practitioners
  5. Physician Assistant, Medical Physician Assistant $256 3% · 7 practitioners

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $3,117 36% · 84 recipients
  2. California $1,223 14% · 8 recipients
  3. New York $1,191 14% · 27 recipients
  4. Maryland $958 11% · 27 recipients
  5. Illinois $811 9% · 27 recipients

The top 5 of 21 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

24,824 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record